Trademark Attorney / Law Firm

Rajiv Jain – Trademark Portfolio

Rajiv Jain specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 11 of 17 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 3 other Nice Classification classes. Filing activity spans from 2006 to 2008. Currently, 0 trademarks are registered.

17 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Rajiv Jain's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

43
Hotels & Restaurants (2 filings)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademark applications has Rajiv Jain filed?

Rajiv Jain has filed 17 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Rajiv Jain specialize in?

Rajiv Jain has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 43 (Hotels & Restaurants). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has Rajiv Jain been filing trademarks?

Rajiv Jain's trademark filing history with the USPTO spans from 2006 to 2008, covering 2 years of trademark practice. During this period, Rajiv Jain has handled 17 trademark applications.

What is Rajiv Jain's trademark registration success rate?

Rajiv Jain has a 0% trademark registration rate, with 0 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.